Mehta Vimal

CIK 00017333691 companyNEW HAVEN, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001733369

Recent Transactions

50 trades

Award
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2026-01-01+199,032→ 200,783 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-09-15−219→ 1,970 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-09-15+219→ 20,493 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-09-14−163→ 816 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-09-14+163→ 20,274 total
Award
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-08-01+18,000→ 18,000 total
Award
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-07-22+15,625→ 20,111 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-06-15−219→ 2,189 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-06-15+219→ 4,486 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-06-14−163→ 979 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-06-14+163→ 4,267 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-03-15+217→ 4,104 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-03-15−217→ 2,408 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2025-03-14+162→ 3,887 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2025-03-14−162→ 1,142 total
Award
BioXcel Therapeutics, Inc.$BTAI
Stock Option (right to buy)
2025-01-07+660,000→ 660,000 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-12-16$0.36/sh−983→ 60,920 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-12-16$0.36/sh−2,134→ 59,605 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-12-15−3,500→ 31,500 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-12-15+3,500→ 61,903 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-12-14−2,610→ 13,049 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-12-14+2,610→ 58,403 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-09-16$0.69/sh−832→ 52,816 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-09-16$0.69/sh−1,150→ 51,666 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-09-15−3,500→ 35,000 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-09-15+3,500→ 53,648 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-09-14+2,609→ 50,148 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-09-14−2,609→ 15,657 total
Award
BioXcel Therapeutics, Inc.$BTAI
Stock Option (right to buy)
2024-07-22+6,250→ 6,250 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-06-17$1.28/sh−2,134→ 47,539 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-06-15+3,500→ 49,673 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-06-15−3,500→ 38,500 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-06-14−2,609→ 18,266 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-06-14+2,609→ 46,173 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-06-05−283,122→ 0 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-06-05$1.58/sh−126,014→ 7,685,501 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Call Options (obligation to sell)
2024-06-04−120→ 120 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-06-04$1.63/sh−126,014→ 7,811,515 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-06-04−283,123→ 283,122 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-06-04−609,221→ 7,937,529 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-04-04$2.62/sh−829→ 48,003 total
Sale
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-04-04$2.62/sh−4,439→ 43,564 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-03-15−14,000→ 42,000 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-03-15+14,000→ 48,832 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2024-03-14−2,610→ 20,875 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2024-03-14+2,610→ 34,832 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2023-12-14−2,609→ 23,485 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2023-12-14+2,609→ 32,222 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Common Stock
2023-09-14+2,610→ 29,613 total
Exercise/Conversion
BioXcel Therapeutics, Inc.$BTAI
Restricted Stock Units
2023-09-14−2,610→ 26,094 total

Companies

BioXcel Therapeutics, Inc.
Director, CEO and President
$BTAI

Recent Filings

Address

C/O BIOXCEL THERAPEUTICS, INC. 555 LONG WHARF DRIVE, 12TH FLOOR

NEW HAVEN, CT, 06511

View on SEC.gov